HEALTH CATALYST INC (HCAT) Stock Income Statement
NASDAQ:HCAT - Nasdaq - US42225T1079 - Common Stock - Currency: USD
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 316.09M | 306.58M | 295.94M | 276.20M | 241.90M | |||
| Cost Of Goods | 170.69M | 164.79M | 161.11M | 142.00M | 124.20M | |||
| Gross Profit | 145.41M | 141.79M | 134.82M | 134.20M | 117.80M | |||
| Operating Expenses | 196.02M | 197.25M | 221.78M | 269.30M | 233.50M | |||
| Research and Development | 54.23M | 56.80M | 68.50M | 72.60M | 61.80M | |||
| Selling, General, and Administrative Expenses | 96.54M | 99.01M | 111.06M | 148.40M | 134.10M | |||
| Operating Income | -50.61M | -55.45M | -86.96M | -135.10M | -115.80M | |||
| Interest Income/Expense | -11.13M | 896.00K | 9.10M | -1.60M | -16.50M | |||
| Other Income/Expense | N/A | -259.00K | 4.00K | -100.00K | 0.00 | |||
| Non Recurring Items | -37.84M | -14.35M | -39.94M | -4.90M | -27.90M | |||
| Income Before Taxes | -99.67M | -69.17M | -117.79M | -141.70M | -160.10M | |||
| Income Tax | 446.00K | 333.00K | 356.00K | -4.30M | -6.90M | |||
| Net Income | -100.12M | -69.50M | -118.15M | -137.40M | -153.20M | |||
| EBITDA | -5.36M | -14.02M | -44.73M | -86.80M | -78.27M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.51 | -1.15 | -2.09 | -2.56 | -3.23 | |||
| Non GAAP EPS | 0.16 | 0.28 | 0.15 | -0.27 | -0.43 | |||
| Statistics | ||||||||
| Gross Profit Margin | 46.00% | 46.25% | 45.56% | 48.59% | 48.70% | |||
| Profit Margin | -31.67% | -22.67% | -39.92% | -49.75% | -63.33% | |||
| Operating Profit Margin | -16.01% | -18.09% | -29.38% | -48.91% | -47.87% | |||
All data in USD